32 related articles for article (PubMed ID: 2484046)
1. Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer.
Song JY; Jo HH; Kim MR; Lew YO; Ryu KS; Cha JH; Kang CS; Donahoe PK; MacLaughlin DT; Kim JH
Int J Oncol; 2012 Jun; 40(6):2013-21. PubMed ID: 22344630
[TBL] [Abstract][Full Text] [Related]
2. Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107.
Barbie TU; Barbie DA; MacLaughlin DT; Maheswaran S; Donahoe PK
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15601-6. PubMed ID: 14671316
[TBL] [Abstract][Full Text] [Related]
3. Lectin bindings and diethylstilbestrol effects on the recognition of mullerian inhibiting substance (MIS) on chick mullerian ducts by MIS-antiserum.
Wang JJ; Yin CS; Teng CS
Histochemistry; 1990; 95(1):55-61. PubMed ID: 2286533
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical demonstration of the binding and internalization of growth hormone in GERL of Chang hepatoma cells.
Wang JJ; Chang JP; Teng CS
Cell Tissue Res; 1990 Nov; 262(2):273-81. PubMed ID: 2076535
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical demonstration of the binding of growth-related polypeptide hormones on chick embryonic tissues.
Wang JJ
Histochemistry; 1989; 93(2):133-41. PubMed ID: 2613553
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody to Mullerian inhibiting substance.
Mudgett-Hunter M; Budzik GP; Sullivan M; Donahoe PK
J Immunol; 1982 Mar; 128(3):1327-33. PubMed ID: 6895760
[TBL] [Abstract][Full Text] [Related]
7. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
[TBL] [Abstract][Full Text] [Related]
8. Cellular localization of müllerian inhibiting substance in the developing rat ovary.
Ueno S; Takahashi M; Manganaro TF; Ragin RC; Donahoe PK
Endocrinology; 1989 Feb; 124(2):1000-6. PubMed ID: 2643506
[TBL] [Abstract][Full Text] [Related]
9. Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo.
Stephen AE; Pearsall LA; Christian BP; Donahoe PK; Vacanti JP; MacLaughlin DT
Clin Cancer Res; 2002 Aug; 8(8):2640-6. PubMed ID: 12171896
[TBL] [Abstract][Full Text] [Related]
10. Antibody against avian müllerian inhibiting substance (MIS) recognizes MIS on rat müllerian duct and human tumor cells.
Wang JJ; Teng CS
Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):267-75. PubMed ID: 2484046
[TBL] [Abstract][Full Text] [Related]
11. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
Ingraham HA; Hirokawa Y; Roberts LM; Mellon SH; McGee E; Nachtigal MW; Visser JA
Recent Prog Horm Res; 2000; 55():53-67; discussion 67-8. PubMed ID: 11036933
[TBL] [Abstract][Full Text] [Related]
12. Genetic studies of MIS signalling in sexual development.
Jamin SP; Arango NA; Mishina Y; Behringer RR
Novartis Found Symp; 2002; 244():157-64; discussion 164-8, 203-6, 253-7. PubMed ID: 11990789
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
